World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
35763
World Ranking
12526
National Ranking
6412

Jason B. Fleming publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jason B. Fleming sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 496 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jason B. Fleming D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jason B. Fleming sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jason B. Fleming is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on fields related to medicine and biochemistry, genetics, and molecular biology, with significant contributions to oncology, molecular biology, cancer research, surgery, and pulmonary and respiratory medicine.

Their main topics of study include pancreatic and hepatic oncology research, cancer genomics and diagnostics, cholangiocarcinoma and gallbladder cancer studies, pancreatitis pathology and treatment, genetic factors in colorectal cancer, economic and financial impacts of cancer, and colorectal cancer treatments and studies.

Key recent publications highlight their continued work in pancreatic cancer and related molecular mechanisms. These include:

  • Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis (2021, Cancer Discovery)
  • DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis (2021, JCI Insight)
  • IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway (2020, Cancer Letters)
  • PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma (2021, Nature Communications)
  • APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis (2021, Nature Cancer)

Jason B. Fleming frequently publishes in the following venues:

  • Journal of Clinical Oncology
  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancers
  • HPB

Their collaboration network includes repeated coauthorships with Jason W. Denbo, Mokenge P. Malafa, Pamela J. Hodul, Jennifer B. Permuth, and Daniel A. Anaya, reflecting sustained research partnerships in their areas of interest.

Best Publications

  • One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

    James C. Yao;Manal Hassan;Alexandria T. Phan;Cecile Dagohoy

  • Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway

    Jaekyoung Son;Costas A. Lyssiotis;Costas A. Lyssiotis;Haoqiang Ying;Xiaoxu Wang

  • Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.

    Leore T. Geller;Michal Barzily-Rokni;Tal Danino;Oliver H. Jonas;Oliver H. Jonas

  • Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function

    Andrea Viale;Piergiorgio Pettazzoni;Costas A. Lyssiotis;Haoqiang Ying

  • Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

    Matthew H.G. Katz;Peter W.T. Pisters;Douglas B. Evans;Charlotte C. Sun

  • MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.

    Surendra K. Shukla;Vinee Purohit;Kamiya Mehla;Venugopal Gunda

  • Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

    Matthew Harold Katz;Matthew Harold Katz;Huamin Wang;Jason B Fleming;Charlotte C Sun

  • KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma

    Jianhua Ling;Ya'an Kang;Ruiying Zhao;Qianghua Xia

  • Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

    Matthew Harold Katz;Jason B Fleming;Priya R Bhosale;Gauri R Varadhachary

  • Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice

    Michael P Kim;Douglas B Evans;Huamin Wang;James L Abbruzzese

  • Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer

    Ryan P. Merkow;Karl Y. Bilimoria;James S. Tomlinson;Jennifer L. Paruch;Jennifer L. Paruch

  • Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression

    Christopher H. Crane;Gauri R. Varadhachary;John S. Yordy;Gregg A. Staerkel

  • Comparison of video trainer and virtual reality training systems on acquisition of laparoscopic skills.

    Elizabeth Costa Hamilton;Daniel J Scott;J. B. Fleming;Robert V Rege

  • LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

    Davide Melisi;Satoshi Ishiyama;Guido M. Sclabas;Jason B. Fleming

  • Emergency Surgery for Colon Carcinoma

    Lane Smothers;Linda Hynan;Jason Fleming;Richard Turnage

  • Sentinel Lymph Node Biopsy Is Accurate After Neoadjuvant Chemotherapy for Breast Cancer

    Tara M. Breslin;Lisa Cohen;Aysegul A Sahin;Jason B. Fleming

  • Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation

    Sunil Krishnan;Awalpreet S. Chadha;Yelin Suh;Hsiang Chun Chen

  • Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature

    Grzegorz Korpanty;Juliet G. Carbon;Paul A. Grayburn;Jason B. Fleming

  • Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference.

    Noelle Sevilir Williams;Richard B. Gaynor;Shane Scoggin;Udit Verma

  • ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic Adenocarcinoma

    Michael P. Kim;Jason B. Fleming;Huamin Wang;James L Abbruzzese

Frequent Co-Authors

Jeffrey E. Lee
Jeffrey E. Lee The University of Texas MD Anderson Cancer Center
Huamin Wang
Huamin Wang The University of Texas MD Anderson Cancer Center
Robert A. Wolff
Robert A. Wolff The University of Texas MD Anderson Cancer Center
Jean Nicolas Vauthey
Jean Nicolas Vauthey The University of Texas MD Anderson Cancer Center
Christopher H. Crane
Christopher H. Crane Memorial Sloan Kettering Cancer Center
James L. Abbruzzese
James L. Abbruzzese Duke University
Douglas B. Evans
Douglas B. Evans Medical College of Wisconsin
Peter W.T. Pisters
Peter W.T. Pisters The University of Texas MD Anderson Cancer Center
Anirban Maitra
Anirban Maitra The University of Texas MD Anderson Cancer Center
Asif Rashid
Asif Rashid The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees in related healthcare fields can open doors to diverse career opportunities within the medical sector. For registered nurses aiming for career advancement, rn to fnp programs provide a streamlined pathway to become a Family Nurse Practitioner, offering increased autonomy and earning potential.

If you have a passion for promoting wellness and healthy lifestyles, consider online nutrition degree programs. These programs can prepare you for roles like nutritionist, dietitian, or health educator, both in hospitals and community settings.

Leadership-oriented students may benefit from pursuing one of the best online mha programs. An online Master of Health Administration equips graduates for management roles in healthcare organizations and systems.

Alternatively, RNs wishing to quickly enhance their credentials without additional clinicals can look into rn bsn online programs no clinicals. These flexible programs are ideal for working professionals ready to expand their scope of practice and pursue higher-level roles.

Best Scientists Citing Jason B. Fleming

Trending Scientists

Recently Published Articles